Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Isoflurane Impacts Murine Melanoma Growth in a Sex-Specific, Immune-Dependent Manner: A Brief Report.

Literature DB >> 29570154

Isoflurane Impacts Murine Melanoma Growth in a Sex-Specific, Immune-Dependent Manner: A Brief Report.

Angela Meier¹, Emilie T E Gross², Jan M Schilling^1,3, Ruth Seelige², Yujin Jung², Endi Santosa², Stephen Searles², Tuo Lin⁴, Xin M Tu⁴, Hemal H Patel^1,3, Jack D Bui².

Abstract

The impact of volatile anesthetics on cancer progression has been observed for decades, but sex differences have not been described. Male and female immune systems vary considerably, and the immune system plays an important role in limiting cancer growth. Currently, mouse models describing the impact of volatile anesthetics on cancer growth are limited to same-sex models. In this brief report, we describe a sex-specific impact of isoflurane on melanoma growth observed in wild-type but not in immune-deficient mice. Future experimental designs related to anesthesia and cancer should evaluate the biological variable of sex in a systematic manner.

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2018 PMID： 29570154 PMCID： PMC5953783 DOI： 10.1213/ANE.0000000000002902

Source DB: PubMed Journal: Anesth Analg ISSN： 0003-2999 Impact factor: 5.108

10 in total

Review 1. Sex differences in immune responses.

Authors: Sabra L Klein; Katie L Flanagan
Journal: Nat Rev Immunol Date: 2016-08-22 Impact factor: 53.106

2. Cervical epidural anesthesia is associated with increased cancer-free survival in laryngeal and hypopharyngeal cancer surgery: a retrospective propensity-matched analysis.

Authors: Fanette Merquiol; Anne-Sophie Montelimard; Alice Nourissat; Serge Molliex; Paul Jacques Zufferey
Journal: Reg Anesth Pain Med Date: 2013 Sep-Oct Impact factor: 6.288

3. Halothane and isoflurane enhance melanoma tumour metastasis in mice.

Authors: G C Moudgil; D P Singal
Journal: Can J Anaesth Date: 1997-01 Impact factor: 5.063

4. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors.

Authors: J Shapiro; J Jersky; S Katzav; M Feldman; S Segal
Journal: J Clin Invest Date: 1981-09 Impact factor: 14.808

5. Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro.

Authors: Laura L Benzonana; Nicholas J S Perry; Helena R Watts; Bob Yang; Iain A Perry; Charles Coombes; Masao Takata; Daqing Ma
Journal: Anesthesiology Date: 2013-09 Impact factor: 7.892

Review 6. Anesthesia and cancer recurrences: The current knowledge and evidence.

Authors: Sukhminder Jit Singh Bajwa; Smriti Anand; Gurpreet Kaur
Journal: J Cancer Res Ther Date: 2015 Jul-Sep Impact factor: 1.805

Review 7. Immune Modulation by Volatile Anesthetics.

Authors: Lindsay M Stollings; Li-Jie Jia; Pei Tang; Huanyu Dou; Binfeng Lu; Yan Xu
Journal: Anesthesiology Date: 2016-08 Impact factor: 7.892

8. Reactive oxygen species by isoflurane mediates inhibition of nuclear factor κB activation in lipopolysaccharide-induced acute inflammation of the lung.

Authors: In Sun Chung; Jie Ae Kim; Ju A Kim; Hyun Sung Choi; Jeong Jin Lee; Mikyung Yang; Hyun Joo Ahn; Sang Min Lee
Journal: Anesth Analg Date: 2013-01-09 Impact factor: 5.108

9. Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis.

Authors: Timothy J Wigmore; Kabir Mohammed; Shaman Jhanji
Journal: Anesthesiology Date: 2016-01 Impact factor: 7.892

Review 10. Hallmarks of cancer: the next generation.

Authors: Douglas Hanahan; Robert A Weinberg
Journal: Cell Date: 2011-03-04 Impact factor: 41.582

10 in total

5 in total

Isoflurane Impacts Murine Melanoma Growth in a Sex-Specific, Immune-Dependent Manner: A Brief Report.

Review 1. Sex differences in immune responses.

2. Cervical epidural anesthesia is associated with increased cancer-free survival in laryngeal and hypopharyngeal cancer surgery: a retrospective propensity-matched analysis.

3. Halothane and isoflurane enhance melanoma tumour metastasis in mice.

4. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors.

5. Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro.

Review 6. Anesthesia and cancer recurrences: The current knowledge and evidence.

Review 7. Immune Modulation by Volatile Anesthetics.

8. Reactive oxygen species by isoflurane mediates inhibition of nuclear factor κB activation in lipopolysaccharide-induced acute inflammation of the lung.

9. Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis.

Review 10. Hallmarks of cancer: the next generation.

1. A Comparison of Ketamine or Etomidate Combined with Xylazine for Intraperitoneal Anesthesia in Four Mouse Strains.

2. Inhibition of SUMO2/3 antagonizes isoflurane-induced cancer-promoting effect in hepatocellular carcinoma Hep3B cells.

Review 3. Effect of Inhalation Anesthetics on Tumor Metastasis.

Review 4. Anesthesia Options and the Recurrence of Cancer: What We Know so Far?

5. The choice of anaesthesia for glioblastoma surgery does not impact the time to recurrence.